Pediatr. praxi. 2007;8(6):379-381

Raynaude phenomenon IN children

MUDr. Vladimír Němec, MUDr. Eva Bočkayová
Dětské oddělení, Krajská nemocnice, Pardubice

The review article is based on literature and personal experience with treatment of these patients in a specialized rheumatologic clinic. At the end of the article they present an algorithm of examination, treatment and follow-up of children with Raynaude phenomenon.

Keywords: Raynaude phenomenon, children, examination, therapy

Published: January 20, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Němec V, Bočkayová E. Raynaude phenomenon IN children. Pediatr. praxi. 2007;8(6):379-381.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Anders HJ, Sigl T. Differentiation between primary and secondary Raynaud´s phenomenon: a prospective study comparing nailfold capillaroscopy using an ophtalmoscope or stereomicroscope. Ann. Rheum. Dis., 2001; 60(4): 407-409. Go to original source... Go to PubMed...
    2. Belch JJ, Ho M. Pharmacotherapy of Raynaud´s phenomenon. Drugs, 1996; 52(2): 682-695. Go to original source... Go to PubMed...
    3. Block JA, Sequeira W. Raynaud´s phenomenon. The Lancet, 2001; 357: 2042-2048. Go to original source... Go to PubMed...
    4. Cassidy TJ, Petty RE. Textbook of pediatric rheumatology W. B. Saunders Company, 2001; 510-512.
    5. Di Giacinto G. The therapy of Raynaud´s phenomenon. Clin. Ter.,1993; 142(2): 161-174. Go to PubMed...
    6. Gonzales PE, Esquinas RG et al. Raynaud phenomenon in childhood. An. Esp. Pediatr., 1998; 48(6): 603-607. Go to PubMed...
    7. Havelka S, Hoza J a kol. Revmatologie období růstu. Maxdorf, 2004, s. 166-167.
    8. Hugdahl K, Fagerström K et al. Effects of cold and mental stress on finger temperature in vasospastics and normals. Behav. Res. Ther., 1984; 22(5): 471-476. Go to original source... Go to PubMed...
    9. Cheng SK, Tiwari A et al. Differentiation of primary and secondary Raynaud´s disease by carotid arterial stiffness. Eur. Vasc. Endovasc. Surg, 2003; 25: 336-341. Go to original source... Go to PubMed...
    10. Kaufman MW at al. Raynaud´s disease: patient education as a primary nursing intervention. J. Vasc. Nurs., 1996; 14(2): 34-39. Go to original source... Go to PubMed...
    11. Martinez S, Lozano P et al. Usefulness of photoplethysmography and indexes of digital pressure in Raynaud phenomenon. Med. Clin.(Barc). 1999; 113(9): 327-330. Go to PubMed...
    12. Neuhauser B, Perkmann P et al. Clinical and objective data of spinal cord stimulation for the treatment of severe Raynaud´s phenomenon. EJVES Extra, 2001; 1: 3-4. Go to original source...
    13. Piťha J, Oliva I. Vazoneurózy. Vnitř. Lék., 1999; 45(7): 433-437. Go to original source...
    14. Planchon B, Pistorius MA et al. Primary Raynaud´s phenomenon. Age of onset and pathogenesis in a prospective study of 424 patients. Angiology, 1994; 45(8): 667-686. Go to original source... Go to PubMed...
    15. Priollet P. Raynaud´s phenomena: diagnostic and treatment study. Rev. Prat., 1998; 48(15):1659-1694. Go to PubMed...
    16. Spencer G. Outcomes in primary Raynaud phenomenon: a meta-analysis of the frequency, rates and predictor of transition to secondary disease. Arch. Intern. Med. 1998; 158(6): 595-600. Go to original source... Go to PubMed...
    17. Turton EP, Kent PT et al. The aetiology of Raynaud's phenomenon. Cardiovasc. Surg., 1998; 6(5): 431-440. Go to original source... Go to PubMed...
    18. Whitaker L, Kelleher A. Raynaud´s syndrome: diagnosis and treatment. J. Vasc. Nurs., 1994; 12(1): 10-13. Go to PubMed...

    Return to the content


    Pediatrics for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.